Herpes Simplex Virus 1 Suppresses the Function of Lung Dendritic Cells via Caveolin-1

Bing Wu1, Shuang Geng2, Yanmin Bi1

  • 1State Key Laboratory for Agro-Biotechnology, College of Biological Science, China Agricultural University, Beijing, People's Republic of China.

Insights

Caveolin-1 (Cav-1) protein hinders the immune response against herpes simplex virus 1 (HSV-1) by reducing nitric oxide (NO) production in dendritic cells (DCs). Blocking Cav-1 enhances viral clearance and reduces lung damage.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Caveolin-1 (Cav-1) is a key structural protein of caveolae, involved in various cellular processes, including virus-host interactions.
  • Several viruses utilize caveolae for entry and replication, but the specific role of Cav-1 in herpes simplex virus 1 (HSV-1) infection remains unclear.

Purpose of the Study:

  • To investigate the role of Cav-1 in dendritic cells (DCs) during HSV-1 infection.
  • To determine the impact of Cav-1 on the host's antiviral response, specifically nitric oxide (NO) production.

Main Methods:

  • Studied the expression of inducible nitric oxide synthase (iNOS) and NO production in DCs from wild-type (WT) and Cav-1 knockout (KO) mice infected with HSV-1.
  • Utilized adoptive transfer of Cav-1 knockdown DCs to WT mice.
  • Administered an iNOS inhibitor to Cav-1 KO mice and assessed survival rates.
  • Examined the colocalization of Cav-1, iNOS, and HSV-1 in infected DCs using microscopy.

Main Results:

  • Cav-1 downregulates iNOS expression and NO production in DCs during HSV-1 infection.
  • Cav-1 deficiency accelerates viral elimination and reduces lung pathology in mice.
  • Protection conferred by Cav-1 knockdown DCs is dependent on iNOS and NO.
  • Inhibition of iNOS in Cav-1 KO mice significantly reduces survival.

Conclusions:

  • Cav-1 acts as a novel regulator exploited by HSV-1 to evade the host's NO-mediated antiviral response.
  • Cav-1 downregulates iNOS and NO production in DCs, impairing the antiviral immunity against HSV-1.
  • Targeting Cav-1 may represent a potential therapeutic strategy for herpesvirus infections.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
47
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.6K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K